drugset / Trial / NCT01936974
(PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma
RandomizedParallel-groupSingle-blindTreatment
Summary
To evaluate progression-free survival with two chemotherapy regimens on platinum-resistant/refractory ovarian and peritoneal carcinoma
Timeline
- Start
- 2013-09
- Primary completion
- 2015-08
- Completion
- 2015-08
Outcome
Outcome not reported
Stopped: “PI Decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Oxaliplatin | Small molecule | — | — |
| Background | Bevacizumab | Monoclonal antibody | — | — |
| Background | Gemcitabine | Small molecule | — | — |